2-Thiazolecarbonitrile

The synthesis of 2-(4-substituted-thiazol-2-yl)acetonitrile intermediates used in the assembly of Type II tyrosine kinase inhibitors initiates with 2-thiazolecarbonitrile as the primary C-2 functionalized heterocyclic building block. Under strictly anhydrous conditions (Karl Fischer moisture ＜50 ppm), 2-thiazolecarbonitrile is dissolved in tetrahydrofuran at −78 °C and treated with a lithium diisopropylamide base to generate the 5-lithiated species; subsequent quenching with an appropriately protected piperazine carboxaldehyde yields the alkylamino alcohol precursor. This process is executed in glass-lined reactors (Pfaudler AE series) equipped with low-temperature direct-expansion refrigeration capable of maintaining jacket temperatures at −85 °C. The addition ratio of 2-thiazolecarbonitrile to the core pyrimidine intermediate is typically maintained at 1.05–1.10 molar equivalents to compensate for localized deactivation at cold spots identified during scale-up campaigns. Regulatory compliance aligns with ICH Q7 Good Manufacturing Practice for active pharmaceutical ingredients and 21 CFR 210/211; residual solvent profiles are controlled in accordance with ICH Q3C Option 2, with daily HPLC analysis (Agilent 1260 Infinity II, C18 column, 210 nm) confirming nitrile content ≥99.0 area% and des-cyano impurity ≤0.15%. The resulting chiral amino alcohol is subsequently cyclized under Mitsunobu conditions to form a substituted thiazolo[5,4-d]pyrimidine core, a privileged scaffold found in ATP-competitive kinase inhibitors. Finished dosage forms are oral capsules or tablets indicated for non-small cell lung carcinoma harboring MET exon 14 skipping mutations. Process safety evaluation includes differential scanning calorimetry screening of the lithiation step to confirm onset of thermal decomposition above 120 °C, well outside the operating window.

What Operational Boundaries Govern the Reductive Amination Sequence When Supplying the 2-Chloro-5-thiazolylmethylamine Moiety for Neonicotinoid Manufacturing?

The conversion of 2-thiazolecarbonitrile into 2-chloro-5-(chloromethyl)thiazole—the pivotal chloroheterocyclic intermediate for clothianidin and thiamethoxam synthesis—passes through a three-stage sequence: catalytic hydrogenation, Sandmeyer-type chlorination, and controlled side-chain halogenation. The initial hydrogenation of the nitrile to the corresponding aminomethyl derivative employs a Raney nickel slurry catalyst (Grace 2800, Ni content ≥85%) in a methanolic ammonia medium at 80–95 °C and 25–35 bar hydrogen pressure. Addition level is critical: 2-thiazolecarbonitrile is charged at a molar ratio of 1.0:1.5 relative to ammonia to suppress secondary amine formation, which otherwise rises to ＞3.0 area% at ammonia deficiencies below 1.2 eq. The hydrogenator—typically a 10,000 L 316L stainless steel autoclave fitted with a Rushton turbine—must maintain an agitator tip speed above 4.5 m/s to ensure gas–liquid mass transfer; deviation leads to prolonged batch times and increased pyrophoric catalyst attrition. Following filtration over a sparkler plate, the aminomethylthiazole solution is diazotized with sodium nitrite (1.03 eq) in hydrochloric acid at −5–0 °C and immediately treated with cuprous chloride to install the chlorine at the 2-position. The chloromethyl side chain is then introduced via radical chlorination using sulfuryl chloride with azobisisobutyronitrile initiation. Compliance is verified against EPA 40 CFR Part 158 data requirements and OECD 506 for residue analysis; the final technical grade material (min. 98.5% purity by GC-FID) is utilized in downstream formulation of suspension concentrates for foliar application. Terminal products include clothianidin 50 WDG water-dispersible granules and thiamethoxam 25 WG, which target hemipteran pests in rice and corn. Real-time reaction monitoring via ReactIR confirms imine intermediate disappearance at 1645 cm⁻¹, preventing over-reduction to the corresponding amine.

Tailoring the dielectric anisotropy (Δε) of fluorinated terphenyl liquid-crystal mixtures for active-matrix TN-TFT displays relies on incorporating a polarizable heterocyclic terminal group, a role fulfilled by the 2-cyanothiazole scaffold. 2-Thiazolecarbonitrile is subjected to a regioselective C-5 Suzuki coupling with 4-(trans-4-propylcyclohexyl)phenylboronic acid using tetrakis(triphenylphosphine)palladium(0) (0.5 mol%) in a toluene/ethanol/water biphasic system at reflux. The molar addition of the boronic acid is held at 0.98 equivalents relative to the thiazolecarbonitrile to facilitate removal of unreacted aryl halide by simple column filtration; excess boronic acid leads to difficult-to-purify homocoupling byproducts that elevate the nematic-to-isotropic transition temperature (T_NI) beyond the 85 °C specification. The resulting 5-aryl-2-cyanothiazole is purified by recrystallization from isopropanol to ＞99.8% GC purity, with ionic residue strictly below 1 ppm sodium and chloride, as measured by ion chromatography (DIN EN ISO 10304-1). Industry standards for display materials apply: IEC 61747-2 for liquid crystal physical properties, REACH (EC) 1907/2006 Annex XVII for substance restrictions, and RoHS 2011/65/EU for homogeneous material lead limits. In the final blended nematic formulation, this cyanothiazole compound typically constitutes 12–18 wt% of the mixture, imparting a Δε of +10.5 to +12.8 (at 1 kHz, 25 °C) and a rotational viscosity suitable for 5 ms response times. End products include 10.1-inch tablet displays and automotive dashboard LCD modules. A notable process risk observed during pilot campaigns: the palladium catalyst residue must be scavenged with a thiol-functionalized silica gel prior to recrystallization, as trace Pd (＞5 ppm) causes photolytic discoloration under UV backlight exposure, a failure mode documented in production lot deviations.

Hydrolysis-Chlorination Cascade to 2-Thiazolecarbonyl Chloride for Thiazolecarboxanilide Fungicides

Thifluzamide and experimental succinate dehydrogenase inhibitor (SDHI) candidates often derive their electrophilic warhead from 2-thiazolecarbonyl chloride, generated directly from 2-thiazolecarbonitrile through alkaline hydrolysis followed by thionyl chloride activation. The nitrile is saponified in aqueous sodium hydroxide (10% w/w) at 90–95 °C over 6–8 hours, with ammonia off-gas absorbed in a packed-bed scrubber; the reaction endpoint is verified by the complete disappearance of the characteristic nitrile stretch at 2225 cm⁻¹ (FTIR). The resulting sodium 2-thiazolecarboxylate solution is acidified to pH 1.5–2.0, and the free acid is isolated by centrifugation and vacuum dried (50 °C, 10 mbar) to moisture ＜0.5% before entering the chlorination stage. 2-Thiazolecarboxylic acid is then suspended in dichloromethane and treated with thionyl chloride (1.3 eq) under catalytic dimethylformamide (0.1 eq) at reflux until gas evolution ceases. The resulting 2-thiazolecarbonyl chloride is used in situ to acylate 2-methyl-4-(trifluoromethoxy)aniline at 0–5 °C in the presence of triethylamine (1.5 eq), yielding thifluzamide after aqueous workup. The molar ratio of nitrile to final anilide is typically 1:0.92, reflecting mechanical losses in acid handling. Production equipment comprises a series of 3,000 L glass-lined reactors with overhead condenser and a Hastelloy C-22 centrifuge. Regulatory conformance is demonstrated through FAO 507/AGP for technical thifluzamide and EPA 40 CFR 180.556 tolerance enforcement for peanuts and rice. The terminal fungicide is formulated as 240 g/L suspension concentrate and used as a seed treatment against Rhizoctonia solani. Failure to dry the free acid below 0.8% moisture results in accelerated corrosion of the thionyl chloride charging line and yields a chlorinated impurity, monochlorothiazole carboxylate, at levels exceeding 0.5%, which cannot be purged downstream.

Heterocyclic azo disperse dyes for polyester sportswear require exhaust affinity and wash fastness that are substantially improved when the diazo component bears a 2-aminothiazole chromophore. 2-Thiazolecarbonitrile is converted to 2-aminothiazole via a modified Hofmann rearrangement: the nitrile is first hydrated to the amide using concentrated sulfuric acid at 40 °C, then treated with sodium hypochlorite in aqueous sodium hydroxide at −10 °C, followed by acid quench to liberate the amine. When incorporated as the diazo component, 2-aminothiazole is diazotized with nitrosylsulfuric acid at 0–5 °C and coupled with N-substituted aniline derivatives such as N-ethyl-N-(2-cyanoethyl)aniline. The stoichiometric addition of 2-thiazolecarbonitrile for a standard 100 kg dye batch translates to 38.5 kg of the raw nitrile, representing a 91% molar efficiency through the three-step sequence. Process safety and environmental compliance are referenced against ZDHC MRSL 3.1 and OEKO-TEX 100 Annex 4 for carcinogenic aryl amines; the final dye must test free of free aromatic amines (＜30 ppm) by EN 14362-1:2017. The resulting dye, typically C.I. Disperse Blue 339, is standardized to 200% strength with lignosulfonate dispersants and applied in high-temperature exhaust dyeing at 130 °C. End products are PET-based athletic apparel and automotive upholstery fabrics. A recurrent processing pitfall is the exothermic nature of the amide dehydration; unless the reactor jacket is equipped with a brine chiller set to −15 °C, the intermediate isocyanide formation can undergo runaway, leading to polymerized tars and yield drops to ＜60%.

Aminothiazole-Derived Intermediates in Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Backbone Construction

Certain diarylpyrimidine NNRTIs under development for HIV-1 treatment incorporate a 2-aminothiazole moiety as a hinge-binding element within the entry channel of the reverse transcriptase enzyme. 2-Thiazolecarbonitrile serves as the direct precursor to 2-aminothiazole through palladium-catalyzed transfer hydrogenation using ammonium formate as the hydrogen donor in methanol at 60 °C. The molar loading of ammonium formate is 4.0 equivalents, and the reaction is performed in a 500 L Hastelloy C-276 reactor under a nitrogen atmosphere to avoid catalyst poisoning. The addition ratio of 2-thiazolecarbonitrile to the subsequent diarylpyrimidine core assembly is typically 1.0 equivalent when the thiazole ring is incorporated via a Buchwald–Hartwig coupling with a 4-bromo-2,6-diarylpyrimidine intermediate using Pd₂(dba)₃/Xantphos (2 mol% Pd) in refluxing dioxane. Compliance with pharmaceutical regulatory frameworks includes ICH M7 (R2) for mutagenic impurity control; a purge factor calculation is submitted to justify control of potentially genotoxic nitrile starting material below the threshold of toxicological concern (1.5 µg/day). The final active pharmaceutical ingredient is crystallized to ＞99.6% purity (HPLC, 254 nm) and formulated as an oral tablet in combination with emtricitabine and tenofovir disoproxil fumarate for pre-exposure prophylaxis. Full-scale manufacturing campaigns have observed that residual palladium above 20 ppm in the isolated 2-aminothiazole promotes debenzylation side reactions during subsequent coupling, underscoring the need for a silica-bound trimercaptotriazine scavenger resin column prior to crystallization.